(2,1,3-Benzothiadiazol-4-yl)methanamine hydrochloride, 95+%, 500mg

DL-glutamic acid, min. 98.5%, for biochemistry, 100 g, plastic packaging.

(3-(Aminomethyl)phenyl)methanol, 95.0%, 5g

4-(4-bromophenyl)-1H-imidazol-2-amine, 98%, 1g

(R)-4-Isopropyl-3-propionyloxazolidin-2-one, 95.0%, 25g

N1,N3-Bis(2,2,6,6-tetramethylpiperidin-4-yl)isophthalamide>96.0%(GC)(T)25g

(S)-Di-tert-butyl 4-oxopyrrolidine-1,2-dicarboxylate, 95.0%, 1g

1-(4-Chlorophenyl)-3-methyl-1H-thieno[2,3-c]pyrazole-5-carboxylic acid, 97%, 10g

[(4-methyl-1,4-oxazepan-6-yl)methyl]amine dihydrochloride, 95.0%, 1g

(2E)-3-(4-bromophenyl)-1-(3-nitrophenyl)prop-2-en-1-one, 95.0%, 10g

3,7-Dimethyloctan-1-ol, 97%, 500g

4-[(1-Piperidino)methyl]phenylmagnesium bromide, 0.25M THF, 97.0%, 500ml

N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethanesulfonamide, 98%, 100mg